Aymen Shatnawi, Andy Maldonado join College of Pharmacy

Roby Hill
September 01, 2022
Aymen Shatnawi and Andy Maldonado

The MUSC College of Pharmacy welcomed two new faculty recently. Aymen Shatnawi joined the Department of Drug Discovery and Biomedical Sciences starting on August 29 and Andy Maldonado joined the Department of Clinical Pharmacy and Outcome Sciences in the spring semester.

Shatnawi is a registered pharmacist who earned a Ph.D. in biomedical sciences, molecular basis of disease, from the University of Toledo in 2008, having earned a master of science in pharmaceutical technology in 1999 and a bachelor of pharmacy in 1995 from the Jordan University of Science & Technology School of Pharmacy in Irbid, Jordan. He also served two postdoctoral fellowships, first at the Duke University Medical Center and then at the Goodman Cancer Center at McGill University in Montreal.

He most recently served as associate professor of pharmaceutical and administrative sciences at the University of Charleston, W.V., where he also served as director of graduate studies. He joined the University of Charleston as assistant professor in 2015, prior to which he served as a clinical pharmacist and consulting pharmacist in Canada.

Maldonado has been affiliated with the MUSC College of Pharmacy for many years, having served as an instructor, guest lecturer, and preceptor for the college’s advanced pharmacy practice experiences and for MUSC’s post-graduate year one (PGY1) and year two (PGY2) residents.

She earned a bachelor of science degree in biology/chemistry from Georgia State University College of Arts & Sciences in 2006 and then her Pharm.D. from the University of Georgia College of Pharmacy. She did her own PGY1 and PGY2 residencies at Grady Health System in Atlanta, specializing the second year in oncology.

She joined MUSC in 2012 as a clinical pharmacist specialist, hematology/oncology, and in 2016 became program director of the PGY2 Oncology Pharmacy Specialty Residency. In 2020, she was named clinical pharmacist for infusion services in MUSC’s Hollings Cancer Center.